Editorial Commentary: Candida glabrata and FKS Mutations: Witnessing the Emergence of the True Multidrug-Resistant Candida
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
(See the Major Article by Alexander et al on pages 1724–32.) The term “multidrug-resistant Candida” has been used loosely in the mycology literature since the early 2000s [1–4]. In 2009, the Clinical and Laboratory Standards Institute subcommittee on antifungal susceptibility testing formally adopted the term, defining multidrug resistance in Candida as resistance or lack of susceptibility to at least 1 drug in 2 or more antifungal classes (unpublished data). Up until recently, this was little more than an academic exercise, as these isolates were usually found buried within very large epidemiologic surveys or in case reports [1, 5, 6]. Case in point: In a recent population-based study of candidemia in the United States, Cleveland et al [7] reported a 7% incidence of fluconazole resistance, 1% incidence of echinocandin resistance, and 0.4% incidence of both echinocandin and fluconazole resistance (8 of 9 isolates were Candida glabrata). The molecular mechanisms of echinocandin resistance were described in parallel to the development of the first echinocandins [8]. Early descriptions were focused on the FKS1/ETG1 mutations [9, 10] and over the years clinicians were reassured because these mutations were, for the most part, created in the laboratory to study resistance and mechanisms of action and because when sporadically found in clinical isolates, correlation with both minimum inhibitory concentrations (MICs) and clinical outcomes was poor [11].
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778 · cited 6×
“However, Alexander et al [12] highlight the emergence of these types of strains and showcase the need for systematic susceptibility testing and further phenotypic and genetic surveillance tied to patient outcomes.”
InfluentialResistance to echinocandin-class antifungal drugs.
Perlin, D. S. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.04.002 · Cited by 512
Cleveland, A. A., Farley, M. M., Harrison, L. H., Stein, B., Hollick, R., Lockhart, S. R., Magill, S. S., Derado, G., Park, B. J., & Chiller, T. M. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis697 · Cited by 366 · cited 2×
“Case in point: In a recent population-based study of candidemia in the United States, Cleveland et al [7] reported a 7% incidence of fluconazole resistance, 1% incidence of echinocandin resistance, and 0.4% incidence of both echinocandin and fluconazole resistance (8 of 9 isolates were Candida glabrata).”
InfluentialPfaller, M. A., Messer, S. A., Moet, G. J., Jones, R. N., & Castanheira, M. (2011) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.02.016 · Cited by 274
Krogh-Madsen, M., Arendrup, M. C., Heslet, L., & Knudsen, J. D. (2006) · Clinical Infectious Diseases · doi:10.1086/500939 · Cited by 201 · cited 1×
“mented resistance against not only azoles and echinocandins, but polyenes as well [13–18]), challenging clinicians with the”
BackgroundArendrup, M. C., Perlin, D. S., Jensen, R. H., Howard, S. J., Goodwin, J., & Hope, W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06369-11 · Cited by 117 · cited 1×
“mented resistance against not only azoles and echinocandins, but polyenes as well [13–18]), challenging clinicians with the”
Background
Cited by
Ahmad, S., & Alfouzan, W. (2021) · Microorganisms · doi:10.3390/microorganisms9040807 · Cited by 269
Fungal Resistance to Echinocandins and the MDR Phenomenon in Candida glabrata
Healey, K. R., & Perlin, D. S. (2018) · Journal of Fungi · doi:10.3390/jof4030105 · Cited by 194
Fungal resistance to echinocandins and the MDR phenomenon in Candida glabrata
Healey, K., & Perlin, D. S. (2018) · doi:10.20944/preprints201808.0306.v1 · Cited by 194
Emerging multidrug-resistant Candida species
Colombo, A. L., Júnior, J. N. D. A., & Guinea, J. (2017) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000411 · Cited by 177
Safety and pharmacokinetics of CD101 IV, a novel echinocandin, in healthy adults
Sandison, T., Ong, V., Lee, J., & Thye, D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01627-16 · Cited by 161
Metadata
- Authors
- Ostrosky-Zeichner, L.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-03-13
- Volume
- 56
- Issue
- 12
- Pages
- 1733-1734
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2108128579
- Cited by
- 51
- References
- 6
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Editorial Commentary: Candida glabrata and FKS Mutations: Witnessing the Emergence of the True Multidrug-Resistant Candida. https://app.cochat.ai/papers/10.1093/cid/cit140
- The paper
- Ostrosky-Zeichner, L. (2013). Editorial Commentary: Candida glabrata and FKS Mutations: Witnessing the Emergence of the True Multidrug-Resistant Candida. Clinical Infectious Diseases. https://doi.org/10.1093/cid/cit140
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.